The complexities of prostate cancer care

As a care partner, it is important to arm yourself with knowledge about the disease. Feel better prepared for discussions with your loved one and his doctor by learning details about prostate cancer, including understanding the prevalence, risk factors, and how to identify progression. 

This photo does not represent an actual patient and care partner.

Prostate cancer is the second most common cancer in the United States1 

In 2025, there were estimated to be 313,780 new cases of prostate cancer1

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, but the risk of developing prostate cancer will vary by person.2

Risk factors for prostate cancer include3:  

  • Older age – Being older than 65 years old
  • Race/ethnicity – prostate cancer is more common in Black men and less common in Asian American, Hispanic, and Latino men
  • Family history – Having a close relative such as a brother or father (or other relatives) with prostate cancer
  • Inherited gene changes – Variations in genes such as BRCA1 or BRCA2 are linked to an increase in the risk of developing certain cancers, including prostate cancer
Healthcare provider and patient in consultation

This photo does not represent an actual patient.

Understanding a prostate cancer diagnosis 

Every prostate cancer diagnosis is different—and so is the journey that follows. While the exact steps may vary by experience, the accompanying timeline gives you a sense of what to expect. Understanding the process can help you feel more prepared and supported at every stage. 

Diagram showing steps in prostate cancer assessment: screening (PSA, DRE), elevated PSA, MRI, biopsy, genetic testing, Genetic test
(germline and/or somatic)
 Staging & risk assessment Biopsy Screening
(PSA test and digital rectal examination) MRI (magnetic resonance imaging) Genetic test
(germline)
Diagram showing steps in prostate cancer assessment: screening (PSA, DRE), elevated PSA, MRI, biopsy, genetic testing, Screening
(PSA test and digital rectal examination) MRI
(magnetic resonance imaging) Biopsy Genetic test
(germline) Staging & risk assessment Genetic test
(germline and/or somatic)

“Even when it was overwhelming, I reminded myself: if I can understand this, I can help him better.”

—Susan*, care partner

*Name changed for care partner privacy.

Prostate cancer screening icon

Screening, including prostate specific antigen (PSA) testing and digital rectal exam (DRE)

Your loved one may undergo screening for prostate cancer such as PSA tests and DREs. PSA is a protein made by the prostate gland. Your loved one may receive PSA tests every 3-6 months to monitor tumor growth, response to treatment, and help detect recurrence of disease. PSA tests determine PSA levels, which are one measure of prostate health. A rising PSA after initial diagnosis and treatment of prostate cancer can indicate that the cancer has come back and could mean your loved one needs more tests to determine if the cancer has returned.4

A digital rectal exam is a quick, routine test that helps doctors check the health of the prostate. During the exam, the healthcare provider gently inserts a lubricated, gloved finger into the rectum to feel the size, shape, and texture of the prostate. This helps detect any unusual changes that may need further evaluation.4

While waiting for PSA test results, focus on enjoying life together. Take walks, watch favorite movies, and cook healthy meals to stay positive and connected

MRI Icon

Further tests, such as imaging and biopsies

If your loved one’s PSA level is outside of the normal range, their doctor will also take into consideration his age, family history, and other details to decide whether further testing is required. For example, a biopsy test or imaging such as MRI may be needed to confirm a cancer diagnosis and understand if and to the extent to which the cancer has spread. If you have any information on family history such as other cancers or awareness of specific genetic mutations, it is important to share this information with your loved one’s doctor.5

When the diagnosis has been confirmed and the degree of disease progression has been established, discussions about appropriate treatment will take place with the medical team.

DNA Icon

Consider genetic testing for your loved one

It’s important to know if your loved one has a genetic mutation that may make them more susceptible to high-risk prostate cancer. Speak to your loved one’s doctor about receiving genetic testing, which can be done by saliva, blood, or biopsy tests, and can determine if they have a BRCA1 or BRCA2 mutation. Knowing their BRCA status can help guide treatment recommendations.6  

You can also help in this process by documenting the types of genetic testing he may receive and informing his doctor of any relevant family history, such as one or more relatives with breast and/or ovarian cancer, a relative with a known BRCA gene mutation, and Ashkenazi Jewish ancestry. You and your loved one may work with a genetic counselor to help guide you through the genetic testing process.

You may hear terms like “germline testing” and “somatic testing”:

  • Germline testing is a type of genetic test that can determine whether a DNA mutation, like BRCA, which is known to increase the risk for certain cancers, has been inherited. This test is usually performed through a cheek swab, saliva sample, or blood sample when they are first diagnosed, particularly if there is a family or personal history that increases risk. If this test comes back as BRCA positive, your loved one's family members should also consider genetic testing6
  • Somatic testing is genetic testing of the tumor, which may be performed through biopsy of the tumor itself if the initial germline test is negative. This will help to confirm the presence of specific DNA mutations such as BRCA. Somatic testing of the tumor typically occurs when cancer has progressed or has spread to other parts of the body.6,7

While genetic testing can provide valuable information about prostate cancer risk, it’s not an easy decision for everyone. Some people feel overwhelmed by the emotional weight of knowing they carry a mutation—especially if there’s no clear course of action. Others worry about the cost of testing, potential impacts on insurance coverage, or how their data will be used and protected. For many, family dynamics add another layer of complexity—navigating whether, when, and how to share results with loved ones. Keep in mind that having knowledge of a genetic mutation may positively impact the treatment approach for your loved one and could provide them a chance for better outcomes.

Knowing if a genetic mutation is present may impact treatment choice and outcomes, so it is critical for your loved one to do genetic testing early

The prostate cancer journey 

Prostate cancer can be diagnosed starting with a routine exam in the doctor’s office or if a man is experiencing symptoms that warrant further evaluation by his doctor through imaging or biopsies. At initial diagnosis, men may have either localized (stage I or II) or advanced prostate cancer (stage III or IV). Every man’s journey with prostate cancer is unique and no two paths look the same.

See the diagram below to learn more about the different prostate cancer paths from diagnosis to treatment.

Prostate cancer diagnosis and treatment process chart, showing steps from primary care referral to urologist, localized or advanced cancer treatment, and follow-up care.
Prostate cancer diagnosis and treatment process chart, showing steps from primary care referral to urologist, localized or advanced cancer treatment, and follow-up care. UROLOGIST PSA TESTS DIGITAL RECTAL EXAM MRI BIOPSY TREATMENT LOW RISK DIAGNOSIS LOCALIZED
PROSTATE CANCER ADVANCED PROSTATE CANCER ACTIVE 
SURVEILLANCE SURGERY RADIOTHERAPY
+/-
HORMONE THERAPY LOCAL WATCHFUL
WAITING NO 
SYMPTOMS PSMA PET Scan METASTATIC HORMONE THERAPY CHEMOTHERAPY RADIOTHERAPY SURGERY (May be an option) HORMONE THERAPY CHEMOTHERAPY RADIOTHERAPY SURGERY (May be an option) SUPPORTIVE CARE (MANAGING SIDE EFFECTS) MONITORING RESPONSE AND RECURRENCE LIVING WITH CANCER SURVIVORSHIP FOLLOW-UP BIOCHEMICAL RECURRENCE PRIMARY CARE PROVIDER GENERAL HEALTH FAMILY HISTORY SYMPTOMS PSA TESTS 1st point of contact REFERRAL

Adapted from: PCahelp.org

Learn more about treatments for localized prostate cancer
Learn more about treatments for advanced prostate cancer
Learn more about treatments for localized prostate cancer
Learn more about treatments for advanced prostate cancer

You are now leaving

Care Partner Corner

Are you sure you want to leave?